UPDATE : Monday, September 7, 2020
상단여백
Newly listed biotech firms perform poorly on KOSDAQ
Biotech companies that went public in the first half of this year have show...
by Nam Doo-hyun  |  2018-10-04 13:09
라인
‘Samsung C&T’s value to rise on BioLogics’ increased value’
Samsung C&T Corp., the parent company of Samsung Group, is likely to enjoy ...
by Nam Doo-hyun  |  2018-10-03 10:11
라인
More doctoral degree holders wanted at biotech ventures
Korean biotech venture companies are increasingly seeking more Ph.D.-qualif...
by Nam Doo-hyun  |  2018-10-02 14:40
라인
Which health agency had highest rise in female worker percentage?
Among health-related government agencies, the Korea Human Resource Developm...
by Nam Doo-hyun  |  2018-10-01 13:38
라인
Samil shares jump on anticipation of fatty liver treatment
Shares of Samil Pharmaceutical spiked on Thursday on investors’ anticipatio...
by Nam Doo-hyun  |  2018-09-28 14:21
라인
Genexine wins nod for immunotherapy trial in combo treatment
Pharmaceutical industry officials are pinning high hopes on combination tre...
by Nam Doo-hyun  |  2018-09-27 11:25
라인
Korea’s drug exports continue to rise in August
The exports of Korean pharmaceutical products continued to expand and excee...
by Nam Doo-hyun  |  2018-09-20 14:23
라인
‘Many Korean hospitals operating in China remain unlawful’
Korean hospitals continue to enter the Chinese market, but most of them are...
by Nam Doo-hyun  |  2018-09-20 14:22
라인
Shares of newly listed biotech firms surge
The stocks of three biotech companies that went public in the second half h...
by Nam Doo-hyun  |  2018-09-19 18:30
라인
‘If you can’t avoid healthcare regulation, enjoy it’
The government regulation is the biggest hurdle for healthcare business but...
by Nam Doo-hyun  |  2018-09-19 14:43
라인
‘Smart hospitals’ to reduce repetitive nursing work
New digital healthcare technologies will significantly reduce repetitive wo...
by Nam Doo-hyun  |  2018-09-17 15:48
라인
Nature Cell shares spike despite investment alert warning
Industry watchers are looking for answers why shares of Nature Cell have be...
by Nam Doo-hyun  |  2018-09-14 16:08
라인
Female workforce scarce in top 15 local pharmaceuticals
Among the top 15 domestic drug companies, Kwangdong Pharmaceutical has the ...
by Nam Doo-hyun  |  2018-09-13 11:41
라인
GC Cell shares spike on winning FDA nod for Immuncell-LC
Stock prices of GC Cell and ToolGen went in the opposite direction on Wedne...
by Nam Doo-hyun  |  2018-09-12 16:05
라인
‘Xgeva reduces risk of bone problems in solid tumor patients’
Amgen Korea’s Xgeva (ingredient: denosumab), a therapy for bone metastases ...
by Nam Doo-hyun  |  2018-09-12 12:23
라인
Hepatitis C patients wait for Maviret’s arrival
Korean physicians and patients have expressed high expectations for AbbVie ...
by Nam Doo-hyun  |  2018-09-11 16:16
라인
‘ToolGen’s KOSDAQ listing might be in peril’
ToolGen, a local biotech firm specialized in gene editing, has been mired i...
by Nam Doo-hyun  |  2018-09-10 14:59
라인
Opdivo-Yervoy okayed as first-line treatment for renal cell carcinoma
The Korean government has approved Ono Pharma Korea and Bristol-Myers Squib...
by Nam Doo-hyun  |  2018-09-06 15:02
라인
CrystalGenomics to export novel drug Acelex to Brazil soon
Acelex, the nation’s 22nd novel drug treating degenerative arthritis, is so...
by Nam Doo-hyun  |  2018-09-04 11:18
라인
Korea’s drug exports to China rebound this year
Korea’s drug exports to China turned around this year amid the easing of tr...
by Nam Doo-hyun  |  2018-08-31 13:10
-12345678910-
176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
여백
Most viewed
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top